Masayuki Isaji Selected Research

Masayuki Isaji Research Topics

7	Insulin Resistance 09/2015 - 07/2005
7	Hyperglycemia 02/2013 - 10/2008
3	Hyperuricemia 01/2016 - 09/2012
2	Fatty Liver 09/2015 - 09/2009
2	Hyperinsulinism (Hyperinsulinemia) 09/2009 - 10/2008
2	Body Weight (Weight, Body) 09/2009 - 05/2009
2	Autoimmune Diseases (Autoimmune Disease) 10/2008 - 08/2008
1	Constipation 07/2017
1	Gout 01/2016
1	Non-alcoholic Fatty Liver Disease 09/2015
1	Ischemia 01/2014
1	Ventricular Tachycardia 01/2014
1	Obesity 09/2009
1	Hypoglycemia (Reactive Hypoglycemia) 05/2009
1	Hypertriglyceridemia 10/2008
1	Diabetes Mellitus 01/2007

10	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 07/2005
4	SodiumIBA 07/2017 - 11/2012
4	Insulin (Novolin)FDA Link 09/2015 - 11/2005
3	SymportersIBA 07/2017 - 11/2012
2	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 01/2016 - 09/2012
2	remogliflozin etabonateIBA 09/2015 - 10/2008
2	Streptozocin (Streptozotocin)FDA Link 08/2012 - 05/2009
2	Sodium-Glucose Transporter 2 InhibitorsIBA 03/2011 - 09/2009
2	sergliflozin etabonateIBA 09/2009 - 05/2009
2	Hypoglycemic Agents (Hypoglycemics)IBA 09/2009 - 01/2007
2	Phosphotransferases (Kinase)IBA 10/2008 - 08/2008
1	Loperamide (Imodium)FDA LinkGeneric 07/2017
1	Lubiprostone FDA Link 07/2017
1	mizagliflozinIBA 07/2017
1	benzimidazoleIBA 01/2016
1	NucleosidesIBA 01/2016
1	Adenine FDA LinkGeneric 01/2016
1	AntioxidantsIBA 09/2015
1	purineIBA 03/2015
1	PhlorhizinIBA 01/2014
1	PurinesIBA 09/2012
1	RNA (Ribonucleic Acid)IBA 09/2012
1	Uric Acid (Urate)IBA 09/2012
1	3- (3- (4- (3- (glucopyranosyloxy)- 5- isopropyl- 1H- pyrazol- 4- ylmethyl)- 3- methylphenoxy)propylamino)propionamideIBA 08/2012
1	Sodium-Glucose Transport ProteinsIBA 09/2009
1	Gliclazide (Diamicron)IBA 05/2009
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	sergliflozinIBA 01/2007
1	Triglycerides (Triacylglycerol)IBA 11/2005
1	Nonesterified Fatty Acids (NEFA)IBA 11/2005
1	Adiponectin ReceptorsIBA 07/2005